News

Lab instruments are important tools throughout research and health care. But what if those instruments are leaking valuable information? When it comes to biosecurity, this could be a very real threat. Researchers found that by simply recording the sounds of a common lab instrument, the team members could reconstruct what a researcher was doing with that instrument.

Researchers have pinpointed a set of enzymes involved in tumor growth that could be targeted to prevent or treat colon cancer.

UCLA scientists have developed a new method to quickly screen hundreds of drugs in order to identify treatments that can target specific tumors. The screening method uses patients' own cells, collected during surgery, to create miniature tumor organoids.

Researchers report that two treatments, cognitive behavioral therapy (counseling) and the drug sertraline, effectively reduce depression among people undergoing maintenance hemodialysis.

A new microfluidic chip separates cancer cells from whole blood or minimally-diluted blood using sticky tags, i.e. affinity separation.

A team has used hydrogels to mimic the environment of lung cancer, selectively allowing cancer cells, and not healthy cells, to invade. This emulated environment enabled their collaborators to screen for both cancer-cell growth and invasion.

At Silicon Valley’s premier chip-design conference, integrated circuit designers unveil technology that they say is 10 times more reliable than current methods of producing unclonable digital fingerprints for Internet of Things devices.

Changing the ventilation settings for children on life support can reduce the risk of damage to their lungs, researchers at the University of Warwick and the Children’s Hospital of Philadelphia have found on computer simulated patients.

In the quest to develop an effective HIV vaccine, researchers have focused attention on identifying and targeting the region of the virus’s outer envelope where a lineage of antibodies are able to dock and neutralize the virus.

University of North Carolina Lineberger Comprehensive Cancer Center researchers have designed a novel way to attack an aggressive breast cancer. By working with a drug development company, they hope their laboratory discovery will translate to a new treatment combination in the clinic in the future.